LOS ANGELES, CA — (Marketwire) — 12/11/09 — Medical Marijuana, Inc. (PINKSHEETS: MJNA) announces today the purchase of 20 acres of prime mountain valley property in Southern California intended to be used within strict governmental guidelines as a research facility targeting medical Cannabis strains specific to a wide range of medical conditions.
Today in California, a physician’s medical cannabis recommendation is based on a patient’s evaluation. However, the strain of medical Cannabis to be recommended, dosage and delivery methods must be refined and re-evaluated.
Many medical conditions are accepted by government as medical marijuana treatable. By diligently developing the most efficacious strains and matching those strains to ailments, MJNA will be poised as the industry leader in medical cannabis genetic research.
Wednesday, March 17, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment